Pioglitazone, a peroxisome proliferator-activated receptor γ activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance

Journal of Molecular and Cellular Cardiology

Volumn 38, Issue 2, 2005, Pages 257-265

  Hasegawa, Hiroshi ^a   Takano, Hiroyuki ^a   Zou, Yunzeng ^a   Qin, Yingjie ^a   Hizukuri, Kaoru ^a   Odaka, Kenichi ^a   Toyozaki, Tetsuya ^a   Komuro, Issei ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Cytokine; Helper T cell; Myocarditis; Peroxisome proliferator activated receptor ; Pioglitazone

Indexed keywords

CARDIAC MYOSIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GENE EXPRESSION; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART WEIGHT; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; INTERMETHOD COMPARISON; MACROPHAGE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; UPREGULATION;

EID: 13444274720     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.11.010     Document Type: Article

References (46)

1. H. Hanawa, M. Tsuchida, Y. Matsumoto, H. Watanabe, T. Abo, and H. Sekikawa Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis. Their similarity to extrathymic T cells in mice and the site of proliferation J. Immunol. 150 1993 5682 5695
2. M. Kodama, Y. Matsumoto, M. Fujiwara, S.S. Zhang, H. Hanawa, and E. Itoh Characteristics of giant cells and factors related to the formation of giant cells in myocarditis Circ. Res. 69 1991 1042 1050
3. D.N. Cook, M.A. Beck, T.M. Coffman, S.L. Kirby, J.F. Sheridan, and I.B. Pragnell Requirement of MIP-1 alpha for an inflammatory response to viral infection Science 269 1995 1583 1585
4. T. Toyozaki, T. Saito, H. Shiraishi, Y. Tsukamoto, H. Takano, and T. Nagai Macrophage inflammatory protein-1alpha relates to the recruitment of inflammatory cells in myosin-induced autoimmune myocarditis in rats Lab. Invest. 81 2001 929 936
5. B.G. Dorner, A. Scheffold, M.S. Rolph, M.B. Huser, S.H. Kaufmann, and A. Radbruch MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines Proc. Natl. Acad. Sci. USA 99 2002 6181 6186
6. W.J. Karpus, N.W. Lukacs, B.L. McRae, R.M. Strieter, S.L. Kunkel, and S.D. Miller An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis J. Immunol. 155 1995 5003 5010
7. K. Schoonjans, J. Peinado-Onsurbe, A.M. Lefebvre, R.A. Heyman, M. Briggs, and S. Deeb PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene EMBO J. 15 1996 5336 5348
8. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
9. H. Takano, T. Nagai, M. Asakawa, T. Toyozaki, T. Oka, and I. Komuro Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes Circ. Res. 87 2000 596 602
10. G.A. Francis, J.S. Annicotte, and J. Auwerx PPAR agonists in the treatment of atherosclerosis Curr. Opin. Pharmacol. 3 2003 186 191
11. M. Asakawa, H. Takano, T. Nagai, H. Uozumi, H. Hasegawa, and N. Kubota Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo Circulation 105 2002 1240 1246
12. H. Takano, H. Hasegawa, T. Nagai, and I. Komuro The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy Drugs Today (Barc) 39 2003 347 357
13. T. Shiomi, H. Tsutsui, S. Hayashidani, N. Suematsu, M. Ikeuchi, and J. Wen Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 106 2002 3126 3132
14. H. Sugiyama, T. Nonaka, T. Kishimoto, K. Komoriya, K. Tsuji, and T. Nakahata Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation Eur. J. Immunol. 30 2000 3363 3370
15. P. Gosset, A.S. Charbonnier, P. Delerive, J. Fontaine, B. Staels, and J. Pestel Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells Eur. J. Immunol. 31 2001 2857 2865
16. M. Okada, S.F. Yan, and D.J. Pinsky Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets FASEB J. 16 2002 1861 1868
17. H. Hasegawa, R. Yamamoto, H. Takano, M. Mizukami, M. Asakawa, and T. Nagai 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats J. Mol. Cell Cardiol. 35 2003 953 960
18. K. Shioji, C. Kishimoto, Y. Nakayama, and S. Sasayama Strain difference in rats with experimental giant cell myocarditis Jpn. Circ. J. 64 2000 283 286
19. K. Ide, H. Hayakawa, T. Yagi, A. Sato, Y. Koide, and A. Yoshida Decreased expression of Th2 type cytokine mRNA contributes to the lack of allergic bronchial inflammation in aged rats J. Immunol. 163 1999 396 402
20. M. Matsubara, S. Masaki, K. Ohmori, A. Karasawa, and K. Hasegawa Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells Biochem. Pharmacol. 67 2004 1315 1326
21. N.W. Lukacs, S.W. Chensue, R.E. Smith, R.M. Strieter, K. Warmington, and C. Wilke Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts Am. J. Pathol. 144 1994 711 718
22. S. Youssef, G. Wildbaum, and N. Karin Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines J. Autoimmun. 13 1999 21 29
23. M. Shimoyama, K. Ogino, Y. Tanaka, T. Ikeda, and I. Hisatome Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts Diabetes 48 1999 609 615
24. C.H. Wang, R.D. Weisel, P.P. Liu, P.W. Fedak, and S. Verma Glitazones and heart failure: critical appraisal for the clinician Circulation 107 2003 1350 1354
25. X. Zhang, and H.A. Young PPAR and immune system--what do we know? Int. Immunopharmacol. 2 2002 1029 1044
26. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
27. S. Boyault, M.A. Simonin, A. Bianchi, E. Compe, B. Liagre, and D. Mainard 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways FEBS Lett. 501 2001 24 30
28. N.S. Wayman, Y. Hattori, M.C. McDonald, H. Mota-Filipe, S. Cuzzocrea, and B. Pisano Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size FASEB J. 16 2002 1027 1040
29. Y. Xu, L. Lu, C. Greyson, J. Lee, M. Gen, and K. Kinugawa Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs Diabetes 52 2003 1187 1194
30. T. Shioi, A. Matsumori, and S. Sasayama Persistent expression of cytokine in the chronic stage of viral myocarditis in mice Circulation 94 1996 2930 2937
31. T. Tsutamoto, A. Wada, T. Matsumoto, K. Maeda, N. Mabuchi, and M. Hayashi Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy J. Am. Coll. Cardiol. 37 2001 2086 2092
32. V. Angeli, H. Hammad, B. Staels, M. Capron, B.N. Lambrecht, and F. Trottein Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response J. Immunol. 170 2003 5295 5301
33. S.W. Chung, B.Y. Kang, and T.S. Kim Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor Mol. Pharmacol. 64 2003 1169 1179
34. R. Ruhl, A. Dahten, F.J. Schweigert, U. Herz, and M. Worm Inhibition of IgE-production by peroxisome proliferator-activated receptor ligands J. Invest. Dermatol. 121 2003 757 764
35. L.J. Saubermann, A. Nakajima, K. Wada, S. Zhao, Y. Terauchi, and T. Kadowaki Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis Inflamm. Bowel Dis. 8 2002 330 339
36. R. Cunard, M. Ricote, D. DiCampli, D.C. Archer, D.A. Kahn, and C.K. Glass Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors J. Immunol. 168 2002 2795 2802
37. J.T. Huang, J.S. Welch, M. Ricote, C.J. Binder, T.M. Willson, and C. Kelly Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase Nature 400 1999 378 382
38. D.O. Gor, N.R. Rose, and N.S. Greenspan TH1-TH2: a procrustean paradigm Nat. Immunol. 4 2003 503 505
39. K. Watanabe, M. Nakazawa, K. Fuse, H. Hanawa, M. Kodama, and Y. Aizawa Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation Circulation 104 2001 1098 1100
40. Y. Okura, K. Takeda, S. Honda, H. Hanawa, H. Watanabe, and M. Kodama Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats Circ. Res. 82 1998 1035 1042
41. C. Natarajan, and J.J. Bright Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation Genes Immun. 3 2002 59 70
42. C. Natarajan, G. Muthian, Y. Barak, R.M. Evans, and J.J. Bright Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis J. Immunol. 171 2003 5743 5750
43. J.S. Welch, M. Ricote, T.E. Akiyama, F.J. Gonzalez, and C.K. Glass PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages Proc. Natl. Acad. Sci. USA 100 2003 6712 6717
44. Z. Yuan, Y. Liu, Y. Liu, J. Zhang, C. Kishimoto, and Y. Wang Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis Cardiovasc. Res. 59 2003 685 694
45. Z. Yuan, Y. Liu, Y. Liu, J. Zhang, C. Kishimoto, and A. Ma Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells J. Cardiovasc. Pharmacol. 43 2004 868 875
46. S. Maruyama, K. Kato, M. Kodama, S. Hirono, K. Fuse, and O. Nakagawa Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats J. Atheroscler. Thromb. 9 2002 87 92